American doctors tracking women being treated for an aggressive form of breast cancer have discovered the drug 'detrimentally affects' how the body responds to cancer treatments.
Robert F. Kennedy Jr., a prominent critic of the pharmaceutical industry, discussed his views regarding GLP-1 weight loss drugs in a televised broadcast.